The prognosis of patients with MPN-related glomerulopathy, unlike those with other glomerulopathies, remains guarded even after corticosteroid therapy, renin-angiotensin system blockade, and treatment of the underlying neoplasm [7]. This evidence concerns the gene REN and lipoprotein glomerulopathy.